Vaccination against varicella: What's the point?

Advances in Experimental Medicine and Biology

Volumn 659, Issue , 2010, Pages 83-87

  Gershon, Anne A ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; HERPES ZOSTER; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; INCUBATION TIME; INFECTION SENSITIVITY; LATENT VIRUS INFECTION; LEUKEMIA; PRIORITY JOURNAL; PROTECTION; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; CHICKENPOX; IMMUNOLOGY; PHYSIOLOGY; REVIEW; VACCINATION; VARICELLA ZOSTER VIRUS; VIROLOGY;

ANIMALS; CHICKENPOX; CHICKENPOX VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; VACCINATION;

EID: 77950362313     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0981-7_7     Document Type: Article

References (24)

1. Aaby, P., Samb, B., Simondon, F. et al. (1996). A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal. Trans R Soc Trop Med Hyg, (90), 326-330. (Pubitemid 26188893)
2. Breuer, J. (2003). Monitoring virus strain variation following infection with VZV: is there a need and what are the implications of introducing the Oka vaccine? Commun Dis Public Health, (6), 59-62.
3. Brunell, P.A. (1977). Commentary: protection against varicella. Pediatrics, (59), 1-2.
4. Brunell, P.A. (1978). Varicella vaccine: the crossroads is where we are not! Pediatrics, (62), 858-859.
5. Centers-for-Disease-Control. (1996). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mort Wkly Rep, (45), 1-36.
6. Chaves, S.S., Gargiullo, P., Zhang, J.X. et al. (2007). Loss of vaccine-induced immunity to varicella over time. N Engl J Med, (356), 1121-1129. (Pubitemid 46425596)
7. Chen, J., Gershon, A., Silverstein, S.J., Li, Z.S., Lungu, O., & Gershon, M.D. (2003). Latent and lytic infection of isolated guinea pig enteric and dorsal root ganglia by varicella zoster virus. J Med Virol, (70), S71-S78. (Pubitemid 36368850)
8. Chen, J.J., Zhu, Z., Gershon, A.A.,&Gershon, M.D. (2004).Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell, (119), 915-926. (Pubitemid 40037606)
9. Gershon, A.A., Arvin, A.M., & Shapiro, E. (2007). Varicella vaccine. N Engl J Med, (356), 2648-2649.
10. Gershon, A.A., Steinberg, S., & Gelb, L. (1984). NIAID-Collaborative- Varicella-Vaccine-Study- Group. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA, (252), 355-362. (Pubitemid 14084794)
11. Gershon, A., Takahashi, M., & Seward, J. (2008). Live attenuated varicella vaccine. In: S. Plotkin, W. Orenstein, & P. Offit (Eds.) Vaccines. pp. 915-958, Philadelphia: WB Saunders.
12. Hardy, I.B., Gershon, A., Steinberg, S., LaRussa, P. et al. (1991). The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med, (325), 1545-1550.
13. Krause, P. & Klinman, D.M. (1995). Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J Pediatr, (127), 518-525.
14. Kuter, B., Matthews, H., Shinefield, H. et al. (2004). Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J, (23), 132-137. (Pubitemid 38222785)
15. Michalik, D.E., Steinberg, S.P., LaRussa, P.S. et al. (2008). Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis, (197), 944-949. (Pubitemid 351590021)
16. Oxman, M.N., Levin, M.J., Johnson, G.R. et al. (2005). A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med, (352), 2271-2284.
17. Provost, P.J., Krah, D.L., Kuter, B.J. et al. (1991). Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine, (9), 111-116.
18. Provost, P., Krah, D., Miller, W. et al. (1989). Comparative sensitivities of assays for antibodies induced by live varicella vaccine. Interscience Conference on Antimicrobial Agents and Chemotherapy.
19. Seward, J.F., Watson, B.M., Peterson, C.L. et al. (2002). Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA, (287), 606-611. (Pubitemid 34252012)
20. Shinefield, H., Black, S., Thear,M. et al. (2006). Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/ hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. Pediatr Infect Dis J, (25), 287-292.
21. Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T., Isomura, S. (1974). Live vaccine used to prevent the spread of varicella in children in hospital. Lancet, (2), 1288-1290.
22. Vazquez, M., LaRussa, P., Gershon, A., Steinberg, S., Freudigman, K., & Shapiro, E. (2001). The effectiveness of the varicella vaccine in clinical practice. N Engl J Med, (344), 955-960. (Pubitemid 32240313)
23. Vazquez, M., LaRussa, P.S., Gershon, A.A. et al. (2004). Effectiveness over time of varicella vaccine. JAMA, (291), 851-855. (Pubitemid 38543773)
24. Williams, V., Gershon, A., & Brunell, P. (1974). Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis, (130), 669-672.